Article Details

Ionis provides update on development program evaluating PCSK9 antisense medicine ... - BioSpace

Retrieved on: 2022-09-23 07:38:53

Tags for this article:

Click the tags to see associated articles and topics

Ionis provides update on development program evaluating PCSK9 antisense medicine ... - BioSpace. View article details on hiswai:

Excerpt

AstraZeneca licensed ION449 from Ionis in 2015. About Hypercholesterolemia. Hypercholesterolemia, or elevated LDL-C levels in the blood, is an ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up